A longtime FDA official who took over last month as the agency’s top drug regulator intends to retire.The departure of ...

The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set to retire just weeks after taking the ...

A CDC panel is reconsidering the birth dose for the hepatitis B vaccine. Renewed doubt could lead to fewer kids getting ...

The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job, according to two ...

Kirk Milhoan has claimed without evidence that the covid-19 shots caused spikes in cancer and miscarriages. Now he's helping ...

A confidential internal memo from the U.S. Food and Drug Administration (FDA) is creating new controversy around vaccine ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

When the federal vaccine committee hand-picked by anti-vaccine Health Secretary Robert F. Kennedy Jr. meets again this week, ...